{"id":"https://openalex.org/W2013797706","doi":"https://doi.org/10.1016/j.jim.2013.04.011","title":"False-positive immunogenicity responses are caused by CD20+ B cell membrane fragments in an anti-ofatumumab antibody bridging assay","display_name":"False-positive immunogenicity responses are caused by CD20+ B cell membrane fragments in an anti-ofatumumab antibody bridging assay","publication_year":2013,"publication_date":"2013-04-29","ids":{"openalex":"https://openalex.org/W2013797706","doi":"https://doi.org/10.1016/j.jim.2013.04.011","mag":"2013797706","pmid":"https://pubmed.ncbi.nlm.nih.gov/23639298"},"language":"en","primary_location":{"id":"doi:10.1016/j.jim.2013.04.011","doi":"https://doi.org/10.1016/j.jim.2013.04.011","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jim.2013.04.011","pdf_url":null,"source":{"id":"https://openalex.org/S201669150","display_name":"Journal of Immunological Methods","issn_l":"0022-1759","issn":["0022-1759","1872-7905"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Immunological Methods","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5047954240","display_name":"Keguan Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Keguan Chen","raw_affiliation_strings":["Clinical Immunology, Biopharm R&D, GlaxoSmithKline, 709 Swedeland Rd., King of Prussia, PA 19406, USA. Keguan.x.chen@gsk.com","Clinical Immunology, Biopharm R&D, GlaxoSmithKline, 709 Swedeland Rd., King of Prussia, PA 19406, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Immunology, Biopharm R&D, GlaxoSmithKline, 709 Swedeland Rd., King of Prussia, PA 19406, USA. Keguan.x.chen@gsk.com","institution_ids":["https://openalex.org/I4210114143"]},{"raw_affiliation_string":"Clinical Immunology, Biopharm R&D, GlaxoSmithKline, 709 Swedeland Rd., King of Prussia, PA 19406, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059261175","display_name":"Jerry G. Page","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jerry G. Page","raw_affiliation_strings":["Clinical Immunology, Biopharm R&D, GlaxoSmithKline, 709 Swedeland Rd., King of Prussia, PA 19406, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Immunology, Biopharm R&D, GlaxoSmithKline, 709 Swedeland Rd., King of Prussia, PA 19406, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018544511","display_name":"Ann Marie Schwartz","orcid":"https://orcid.org/0000-0002-3223-4405","observed_orcids":["https://orcid.org/0000-0002-3223-4405"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ann M. Schwartz","raw_affiliation_strings":["Clinical Immunology, Biopharm R&D, GlaxoSmithKline, 709 Swedeland Rd., King of Prussia, PA 19406, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Immunology, Biopharm R&D, GlaxoSmithKline, 709 Swedeland Rd., King of Prussia, PA 19406, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Thomas N. Lee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas N. Lee","raw_affiliation_strings":["Clinical Immunology, Biopharm R&D, GlaxoSmithKline, 709 Swedeland Rd., King of Prussia, PA 19406, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Immunology, Biopharm R&D, GlaxoSmithKline, 709 Swedeland Rd., King of Prussia, PA 19406, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042823676","display_name":"Stephen L. DeWall","orcid":"https://orcid.org/0000-0002-8119-5748","observed_orcids":["https://orcid.org/0000-0002-8119-5748"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen L. DeWall","raw_affiliation_strings":["Clinical Immunology, Biopharm R&D, GlaxoSmithKline, 709 Swedeland Rd., King of Prussia, PA 19406, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Immunology, Biopharm R&D, GlaxoSmithKline, 709 Swedeland Rd., King of Prussia, PA 19406, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110036423","display_name":"Daniel J. Sikkema","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel J. Sikkema","raw_affiliation_strings":["Clinical Immunology, Biopharm R&D, GlaxoSmithKline, 709 Swedeland Rd., King of Prussia, PA 19406, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Immunology, Biopharm R&D, GlaxoSmithKline, 709 Swedeland Rd., King of Prussia, PA 19406, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5026190610","display_name":"Catherine Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Catherine Wang","raw_affiliation_strings":["Clinical Immunology, Biopharm R&D, GlaxoSmithKline, 709 Swedeland Rd., King of Prussia, PA 19406, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Immunology, Biopharm R&D, GlaxoSmithKline, 709 Swedeland Rd., King of Prussia, PA 19406, United States","institution_ids":["https://openalex.org/I4210114143"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5047954240"],"corresponding_institution_ids":["https://openalex.org/I4210114143"],"apc_list":{"value":2970,"currency":"USD","value_usd":2970},"apc_paid":null,"fwci":2.0117,"has_fulltext":false,"cited_by_count":33,"citation_normalized_percentile":{"value":0.85539556,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"394","issue":"1-2","first_page":"22","last_page":"31"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.8910999894142151,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.8910999894142151,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.09210000187158585,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11314","display_name":"Clinical Laboratory Practices and Quality Control","score":0.003100000089034438,"subfield":{"id":"https://openalex.org/subfields/3607","display_name":"Medical Laboratory Technology"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cd20","display_name":"CD20","score":0.7239999771118164},{"id":"https://openalex.org/keywords/matrix-effects","display_name":"matrix effects","score":0.7350000143051147},{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.8669999837875366},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.7689999938011169},{"id":"https://openalex.org/keywords/immunodepletion","display_name":"immunodepletion","score":0.8529999852180481},{"id":"https://openalex.org/keywords/ofatumumab","display_name":"ofatumumab","score":0.8859999775886536}],"concepts":[{"id":"https://openalex.org/C2778714382","wikidata":"https://www.wikidata.org/wiki/Q410656","display_name":"Ofatumumab","level":4,"score":0.9708665609359741},{"id":"https://openalex.org/C18031839","wikidata":"https://www.wikidata.org/wiki/Q5009796","display_name":"CD20","level":3,"score":0.8133856654167175},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.5871404409408569},{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.5866514444351196},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5126549601554871},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.43307533860206604},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.38190436363220215},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3744075298309326},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3331281244754791},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.26587507128715515}],"mesh":[{"descriptor_ui":"D000906","descriptor_name":"Antibodies","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D001402","descriptor_name":"B-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D005189","descriptor_name":"False Positive Reactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008565","descriptor_name":"Membrane Proteins","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D018613","descriptor_name":"Microscopy, Confocal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018951","descriptor_name":"Antigens, CD20","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.jim.2013.04.011","doi":"https://doi.org/10.1016/j.jim.2013.04.011","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jim.2013.04.011","pdf_url":null,"source":{"id":"https://openalex.org/S201669150","display_name":"Journal of Immunological Methods","issn_l":"0022-1759","issn":["0022-1759","1872-7905"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Immunological Methods","raw_type":"journal-article"},{"id":"pmid:23639298","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23639298","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of immunological methods","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":35,"referenced_works":["https://openalex.org/W60759546","https://openalex.org/W1721657566","https://openalex.org/W1964505291","https://openalex.org/W1967295501","https://openalex.org/W1969002010","https://openalex.org/W1986321004","https://openalex.org/W1998589953","https://openalex.org/W2014847357","https://openalex.org/W2015007424","https://openalex.org/W2015021549","https://openalex.org/W2017416510","https://openalex.org/W2020622193","https://openalex.org/W2030125105","https://openalex.org/W2033928749","https://openalex.org/W2040935430","https://openalex.org/W2041194043","https://openalex.org/W2051678321","https://openalex.org/W2064215099","https://openalex.org/W2067768484","https://openalex.org/W2069160250","https://openalex.org/W2069506532","https://openalex.org/W2082620902","https://openalex.org/W2086121127","https://openalex.org/W2110039271","https://openalex.org/W2117486036","https://openalex.org/W2138572955","https://openalex.org/W2141111992","https://openalex.org/W2142184993","https://openalex.org/W2148766690","https://openalex.org/W2160690356","https://openalex.org/W2161563262","https://openalex.org/W2993728536","https://openalex.org/W4238278421","https://openalex.org/W4244331421","https://openalex.org/W6771498656"],"related_works":["https://openalex.org/W4283207527","https://openalex.org/W2063851754","https://openalex.org/W7138966095","https://openalex.org/W4400693502","https://openalex.org/W2998312497","https://openalex.org/W4392078709","https://openalex.org/W2018041017","https://openalex.org/W1964924603","https://openalex.org/W4414312939","https://openalex.org/W2054468656"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}